Baseline characteristics of the two groups
| Web group(n=37) | Control group(n=23) | |
| Gender | ||
| Male, n (%) | 33 (89) | 21 (9) |
| Age | ||
| Mean (SD) | 62 (10) | 61 (8) |
| Ethnicity | ||
| White, n (%) | 37 (100) | 21 (91) |
| Marital status | ||
| Married, n (%) | 27 (75) | 17 (74) |
| BMI | ||
| Mean (SD) | 28 (11) | 29 (12) |
| Family history | ||
| Yes, n (%) | 20 (54) | 6 (26) |
| Employment status, n (%) | ||
| Employed | 14 (38) | 9 (39) |
| Self-employed | 1 (3) | 1 (4) |
| Retired | 21 (57) | 12 (52) |
| Part-time and retired | 1 (3) | 0 (0) |
| Unpaid work and retired | 0 (0) | 1 (4) |
| Previous cardiac event, n (%) | ||
| IHD (Ischaemic Heart Disease) | 7 (19) | 1 (4) |
| Angina | 9 (24) | 6 (26) |
| PCI | 6 (16) | 4 (17) |
| Cardiac arrest | 5 (14) | 2 (9) |
| Other | 10 (27) | 10 (44) |
| Medication, n (%) | ||
| Beta blockers | 33 (89) | 18 (78) |
| ACE (Angiotensin Converting Enzyme) inhibitors | 32 (87) | 19 (83) |
| GTN (Glyceryl Trinitrate) spray | 29 (78) | 20 (87) |
| Anticoagulants | 19 (51) | 11 (48) |
| Aspirin | 35 (95) | 21 (91) |
| Statins | 35 (95) | 21 (91) |
| Diuretics | 9 (24) | 2 (9) |
| Calcium channel blocker | 4 (11) | 5 (22) |
| Antiarrhythmic | 6 (16) | 16 (70) |
BMI, body mass index;GTN, Glyceryl trinitrate; IHD, Ischeamic heart disease; PCI, percutaneous coronary intervention.